# Combination Therapy of Microwave Ablation and Cellular Immunotherapy for Hepatocellular Carcinoma

> **NCT02851784** · PHASE2,PHASE3 · COMPLETED · sponsor: **Chinese PLA General Hospital** · enrollment: 40 (actual)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **BIOLOGICAL:** adoptive immunotherapy
- **PROCEDURE:** MWA

## Key facts

- **NCT ID:** NCT02851784
- **Lead sponsor:** Chinese PLA General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-12
- **Primary completion:** 2020-07-30
- **Final completion:** 2021-03-01
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2021-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02851784

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02851784, "Combination Therapy of Microwave Ablation and Cellular Immunotherapy for Hepatocellular Carcinoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02851784. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*